Company news
Zero Candida Technologies Inc. (TSXV:ZCT) news
Zero Candida Technologies Inc. news releases on 6ix. Latest, Jun 24, 2026: Zero Candida announced officially been granted Patent No. 12654025B2…
Press releases & updates
Zero Candida announced officially been granted Patent No. 12654025B2 -- a meaningful milestone that reflects our commitment to innovation, technology, and long-term impact
June 24, 2026
Zero Candida Announces Corporate Changes
May 25, 2026
Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device
February 17, 2026
Zero Candida Achieves Design Freeze and Begins Prototype Production of ZC-001 Therapeutic Device
October 20, 2025
Zero Candida Technologies Reports Financial Results for Three and Six Months Ended June 30, 2025 and Provides Business Update
September 3, 2025
OTCQB Venture Virtual Investor Conference: Presentations Now Available for Online Viewing
August 8, 2025
Zero Candida Technologies to Present at the OTCQB Venture Virtual Investor Conference on August 7th
August 5, 2025
Zero Candida Technologies Announces DTC Eligibility and to Present at OTCQB Venture Virtual Investor Conference on August 7th
August 5, 2025
OTCQB Venture Virtual Investor Conference Agenda Announced for August 7th
August 4, 2025
Zero Candida Technologies Reports Full Year 2024 Financial Results and Business Highlights
April 2, 2025
Zero Candida Commences Trading on OTCQB Market
March 12, 2025
Zero Candida Technologies Inc. (ZCT) Opens the Market
November 25, 2024
Zero Candida Applies to List its Shares on the TSX Venture Exchange
November 18, 2024